9VWT
The catalytic domain of human plasma kallikrein with peptide inhibitor 070
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SSRF BEAMLINE BL17U |
Synchrotron site | SSRF |
Beamline | BL17U |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2014-12-20 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.979 |
Spacegroup name | P 65 |
Unit cell lengths | 91.037, 91.037, 57.480 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 32.530 - 1.770 |
R-factor | 0.18514 |
Rwork | 0.184 |
R-free | 0.20992 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.010 |
RMSD bond angle | 1.848 |
Data reduction software | HKL-3000 |
Data scaling software | HKL-3000 |
Phasing software | MOLREP |
Refinement software | REFMAC (5.8.0430) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 1.830 |
High resolution limit [Å] | 1.770 | 1.770 |
Rmeas | 0.117 | 0.443 |
Number of reflections | 26165 | 2610 |
<I/σ(I)> | 17.34 | 11.49 |
Completeness [%] | 98.9 | 100 |
Redundancy | 7.4 | 7.5 |
CC(1/2) | 0.985 | 0.949 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 298 | PEG 3350, TRIS-HCL, (NH4)2SO4 |